Breast cancer chemotherapy regimens used in the real-world setting were examined. Chemotherapy modifications varied markedly by regimen and by characteristics of the regimen administered. Given that more than one in three women in this cohort did not receive chemotherapy as intended, these novel findings may be informative in treatment planning and for future research assessing real-world treatment effectiveness.
Bhimani et al. (Wed,) studied this question.